Zanucco, E., N. El-Nikhely, R. Gotz, K. Weidmann, V. Pfeiffer, R. Savai, W. Seeger, A. Ullrich and U. R. Rapp: Elimination of B-RAF in oncogenic C-RAF-expressing alveolar epithelial type II cells reduces MAPK signal intensity and lung tumor growth. In: J Biol Chem 289, 39, 26804-26816 (2014).
Bezler, M., J. G. Hengstler and A. Ullrich: Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells. In: Molecular Oncology 6, 5, 516-529 (2012).
Bender, C. and A. Ullrich: PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma-cell lines. In: International Journal of Cancer 131, 2, E45-E55 (2012).
Beji, A., D. Horst, J. Engel, T. Kirchner and A. Ullrich: Toward the Prognostic Significance and Therapeutic Potential of HER3 Receptor Tyrosine Kinase in Human Colon Cancer. In: Clinical Cancer Research 18, 4, 956-968 (2012).
Keri, G. and A. Ullrich: PREFACE. In: Current Signal Transduction Therapy 7, 1, 1-1 (2012).
Tateno, T., S. L. Asa, L. Zheng, T. Mayr, A. Ullrich and S. Ezzat: The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis. In: PLoS Genetics 7, 12, e1002400-e1002400, Seq. No.: e1002400 (2011).
doi: 10.1371/journal.pgen.1002400
Alokail, M. S., N. M. Al-Daghri, O. S. Al-Attas, K. M. Alkharfy, S. B. Sabico and A. Ullrich: Visceral obesity and inflammation markers in relation to serum prostate volume biomarkers among apparently healthymen. In: European Journal of Clinical Investigation 41, 9, 987-994 (2011).
Ullrich, A.: From Genes to Cancer Therapies. In: European Journal of Cancer 47, Suppl. 1, S54-S54 (2011).
Ullrich, A., M. Rohrschneider, G. Scheuermann, P. F. Stadler and C. Flamm: In silico evolution of early metabolism. In: Artificial Life 17, 2, 87-108 (2011).
localid: training52742
Chua, B. T., S. J. Lim, S. C. Tham, W. J. Poh and A. Ullrich: Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells. In: Molecular Oncology 4, 4, 323-334 (2010).
The Max Planck Society does not take any responsibility for the content of this export.